Investing in Cannabis Testing Labs and Expansion of Marijuana News Focus of DigiPath

DigiPath, Inc. (OTCBB and OTCQB: DIGP), the independent cannabis testing, media, digital pathology, and education firm, announced the filing of its quarterly report on Form 10-Q for its second fiscal quarter ended March 31, 2015, with the Securities and Exchange Commission.

"DigiPath ended the quarter with $3.9 million of stockholders' equity," says David Williams, DigiPath's CFO. "We completed the purchase and installation of our state-of-the-art cannabis testing equipment, created our testing protocols, and expect to begin generating revenues from our significant investments later this quarter."

DigiPath's second quarter performance includes a 170% increase in revenue over last year, rising to $136,000 from $51,000 for the quarters ended March 31, 2015 and 2014, respectively. Year-to-date revenue is up 194%, climbing to $310,000 from $106,000 for the six-month periods ended March 31, 2015 and 2014, respectively.

SG&A and R&D expenses were controlled and came in slightly below last quarter's...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.asianhhm.com/pressreleases/investing-in-cannabis-testing-labs-and-expansion-of-marijuana-news-focus-of-digipath-inc-10-q